CHANGES OF ANGIOGENIC FACTORS AND MARKERS OF ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADOLESCENTS OF WILSON-KONOVALOV DISEASE
- Authors: Batyrova A.S.1, Vasilyeva E.M1, Bakanov M.I1, Surkov A.N2
-
Affiliations:
- National Medical Research Center for Children’s Health
- Centralized clinical diagnostic laboratory with express diagnostics group of the Laboratory Department of the Institute of Pediatrics of National Medical Research Center for Children’s Health
- Issue: Vol 24, No 6 (2018)
- Pages: 295-298
- Section: Articles
- URL: https://journals.rcsi.science/0869-2106/article/view/38470
- DOI: https://doi.org/10.18821/0869-2106-2018-24-6-295-298
- ID: 38470
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Anna S. Batyrova
National Medical Research Center for Children’s Health
Email: annbatyrova@yandex.ru
doctor of clinical laboratory diagnostics Centralized clinical diagnostic laboratory with express diagnostics group of the Laboratory Department of the Institute of Pediatrics of National Medical Research Center for Children’s Health, 119991, Moscow, Russian Federation 119991, Moscow, Russian Federation
E. M Vasilyeva
National Medical Research Center for Children’s Health119991, Moscow, Russian Federation
M. I Bakanov
National Medical Research Center for Children’s Health119991, Moscow, Russian Federation
A. N Surkov
Centralized clinical diagnostic laboratory with express diagnostics group of the Laboratory Department of the Institute of Pediatrics of National Medical Research Center for Children’s Health119991, Moscow, Russian Federation
References
- Гарбузенко Д.В. Морфофункциональная перестройка печеночного сосудистого русла в патогенезе портальной гипертензии при циррозе печени (обзор литературы). Терапевтический архив. 2014; 2: 90-5
- Lozano R., Naghavi M., Foreman K., Lim S., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859): 2095-0128. doi: 10.1016/S0140-6736(12) 61728-0
- Folkman J. Angiogenesis: in organizing principle for drug discovery? Nat.Rev.Drug.Discov. 2007. 6(4): 273-286. doi: 10.1038/nrd2115
- Salsedo X., Medina J., Sanz-Cameno P., Garcia-Buey L., Martin-Vilchez S., Moreno-Otero R. Review article: angiogenesis soluble factors as liver disease markers. Aliment Pharmacol. Ther. 2005; 22: 23-30. doi: 10.1111/j.1365-2036.2005.02532.x
- Fernández-Iglesias A., Gracia-Sancho J. How to Face Chronic Liver Disease: The Sinusoidal Perspective. Front Med (Lausanne). 2017; 4 (7): 1-10. doi: 10.3389/fmed.2017.00007
- Гарбузенко Д.В. Механизмы компенсации структуры и функции печени при ее повреждении и их практическое значение. Рос. журнал гастроэнтерологии, гепатологии, колопроктологии. 2008; 6 (XVIII): 14-21
- Makhlouf M.M., Awad A., Zakhari A.A. et al. Vascular endothelial growth factor level in chronic liver diseases. J. Egypt. Soc. Parasitol. 2002; 32 (3): 907-21
- Батырова А.С., Баканов М.И., Сурков А.Н. Состояние системы ремоделирования сосудов и ангиогенеза печени при хронических формах её патологии (обзор литературы). Патологическая физиология и экспериментальная терапия. 2016; 60 (1): 73-8.
- Парфенова Е.В., Ткачук В.А. Терапевтический ангиогенез: достижения, проблемы, перспективы. Кардиологический вестник. 2007; 2: II (XIV): 5-15.
- Melincovici C.S., Boşca A.B., Şuşman S., Mărginean M., Mihu C., Istrate M. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol. Embryol. 2018. 59(2): 455-67.
- Sharma PS., Sharma R., Tyagi T. VEGF/VEGFR pathway inhibitors as anti-angiogenic agents: present and future. Curr. Cancer Drug Targets. 2011; 11 (5): 624-53.
- Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011; 473: 298-307. doi: 10.1038/nature10144
- Wu F.T.H., Stefanini MO., Gabhann FM., Kontos CD., Annex BH. et. al. A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. J. Cell. Mol. Med. 2010; 14 (3): 528-52. doi: 10.1111/j.1582-4934.2009.00941.x
- Tripodi A., Mannuccio P. The coagulopathy of chronic liver disease. N Engl J Med. 2011; 365(2): 147-56. doi: 10.1056/NEJMra1011170
- Cahill P.A., Redmond E.M., Sitzmann J.V. Endothelial dysfunction in cirrosis and portal hypertension. Pharmacol. Ther. 2001; 89: 273-93
- Батырова А.С., Баканов М.И., Сурков А.Н. Современные представления о системе гемостаза при хронических заболеваниях печени (обзор литературы). Клиническая лабораторная диагностика. 2015; 60 (8): 40-4